The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
E-cigarette maker Juul Labs Inc.'s sales have been halted on two websites in China, just days after it launched in the world's biggest tobacco market.Biotech and Pharmaceuticalsread more
Investors might be wary that gasoline prices will continue to rise, and are looking to take back profits by selling off shares.Retailread more
The Trump administration move on California's auto emissions standards would likely set up a fight between the White House and the state.Politicsread more
"I feel really confident that defense-minded CEOs, when they are on defense, they're going to come to" flexible offices and away from traditional leases, Knotel CEO Amol Sarva...Commercial Real Estateread more
Fanatics has hired Michener Chandlee, Nike's corporate audit and chief risk officer, to become its chief financial officer, succeeding Lauren Cooks Levitan, CNBC has learned.Retailread more
"Pharma bro" scammer Martin Shkreli has been sent to a federal prison in New Jersey to serve the remainder of his seven-year sentence after being denied his request for a minimum-security federal camp.
Shkreli, who had been in a Brooklyn federal jail since September, was shipped Tuesday to the low-security Fort Dix Federal Correctional Institution in New Jersey, according to the U.S. Bureau of Prisons.
The prison is located on the U.S. military base at Fort Dix, about 80 miles from New York City, where Shkreli lived, and 30 miles from Philadelphia. It houses 3,945 inmates.
His sentencing judge endorsed that request. But the Bureau of Prisons has the last word in determining where to place its inmates.
Shkreli's lawyer Benjamin Brafman declined to comment Wednesday.
Brafman previously said that Judge Kiyo Matsumoto's ruling last September that Shkreli was a public danger would prevent him from being sent to a minimum-security camp because of BOP guidelines.
Camps are considered safer for inmates and are relatively more pleasant places to do one's sentence than facilities that have higher security designations.
Matsumoto had said Shkreli was a danger as she revoked his bail for, among other things, his bizarre offer to Facebook followers of $5,000 for each strand of hair they managed to pull off the head of Hillary Clinton, who at the time was in the midst of a book tour.
Shkreli until then had been free on $5 million bail despite being convicted in August of defrauding a group of hedge-fund investors and of manipulating the stock of a drug company he founded, Retrophin.
Fort Dix's past inmates have included Buddy Cianci, the corrupt mayor of Providence, Rhode Island; high-ranking Patriarca crime family boss Matthew Gugliemetti Jr., and George Jung, the former cocaine kingpin portrayed by actor Johnny Depp in the film "Blow."
Fort Dix also has housed Martin Frankel, the insurance swindler whose crimes led to $200 million in losses. Frankel was featured on CNBC's crime show "American Greed," as was Shkreli, recently.
Matsumoto last month sentenced Shkreli to seven years in prison. She also ordered that he forfeit almost $7.4 million to the federal government, and pay a $75,000 fine.
Shkreli first gained public notoriety in 2015 when he raised the price of the anti-parasite drug Daraprim by more than 5,000 percent while heading another pharmaceuticals company then known as Turing. The company since has changed its name to Vyera Pharmaceuticals.